e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Pleural infection and complicated pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The role of Procalcitonin in management of pleural infections
S. Mohannad (kettering, United Kingdom), Y. Vali (kettering, United Kingdom), M. Naeem (kettering, United Kingdom), G. Tsaknis (kettering, United Kingdom), R. Reddy (kettering, United Kingdom)
Source:
International Congress 2019 – Pleural infection and complicated pneumonia
Session:
Pleural infection and complicated pneumonia
Session type:
Poster Discussion
Number:
3837
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Mohannad (kettering, United Kingdom), Y. Vali (kettering, United Kingdom), M. Naeem (kettering, United Kingdom), G. Tsaknis (kettering, United Kingdom), R. Reddy (kettering, United Kingdom). The role of Procalcitonin in management of pleural infections. 3837
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Serum Procalcitonin for diagnosing and monitoring response in pleural infection
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019
Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions?
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011
The study of the role of procalcitonin (PCT) in early detection of nosocomial infections in chest patients
Source: Annual Congress 2008 - Mechanical ventilation and airway management
Year: 2008
Thoracoscopy in the management of pleural infection
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014
Role of markers C-Reactive Protein, Procalcitonin and TREM-1 in diagnosis of infection pleural effusion
Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management
Year: 2018
The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
Procalcitonin as a diagnostic tool in systemic bacterial sepsis
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009
Procalcitonin has wider applicability in community-acquired pneumonia than other biomarkers
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
How can radiology assist in the diagnosis and management of pleural infection
Source: International Congress 2018 – Management of pleural infection in 2018
Year: 2018
Serum procalcitonin as a potential biomarker of surgery in parapneumonic pleural effusions
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Pleural fluid procalcitonin levels in identifying pleural effusions due to infection
Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Year: 2009
Predictive factors, microbiology and outcome of patients with parapneumonic effusion
Source: Eur Respir J 2011; 38: 1173-1179
Year: 2011
The role of procalcitonin in the differential diagnosis and in the response to treatment of lower respiratory tract infections
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia
Source: International Congress 2015 – CAP: prognostic factors in frail patients
Year: 2015
Procalcitonin to complement microbiology in LRTI and other infections
Source: Annual Congress 2008 - Improved diagnosis and clinical decision-making by integrating information from new biomarkers
Year: 2008
Protein profiling of pleural fluid in guiding management of infectious parapneumonic effusion in children
Source: International Congress 2015 – Paediatric pulmonary infections
Year: 2015
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009
I like invasive techniques to define their role in the diagnosis of pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009
The role of bronchoscopy in pleural diseases
Source: ERS Skills course - Medical thoracoscopy
Year: 2017
Procalcitonin in respiratory disease: use as a biomarker for diagnosis and guiding antibiotic therapy
Source: Breathe, 15 (4) 296; 10.1183/20734735.0258-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept